Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $0 | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 | $0 |
| Gross margin | — | — | — | — | — |
| R&D | $12.5M | $24.0M | $27.2M | $44.7M | $54.7M |
| Operating income | −$18.6M | −$31.2M | −$37.2M | −$64.8M | −$76.5M |
| EBITDA | −$17.6M | −$30.1M | −$37.2M | −$62.9M | −$71.8M |
| Net income | −$18.0M | −$30.2M | −$46.8M | −$64.7M | −$78.3M |
| Net margin | — | — | — | — | — |
| EPS (diluted) | -1.97 | -2.42 | -7.69 | -2.56 | -3.02 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds ONCR.
No tracked institution reports a position in ONCR as of their last filing.
No one on the platform has traded ONCR yet.
| — |
| GRTSGritstone bio, Inc. | $0.03 | -31.78% | $4M | — |
| IDRAIdera Pharmaceuticals, Inc. | $0.42 | -23.04% | $0 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$ONCR ONCORUS, Inc. (NASDAQ:ONCR): Transforming Cancer Treatment with Innovative Self-Amplifying RNA Immunotherapies https://beyondspx.com/article/oncorus-inc-nasdaq-oncr-transforming-cancer-treatment-with-innovative-self-amplifying-rna-immunotherapies
View on StockTwits ↗$ONCR ONCORUS, Inc. (NASDAQ:ONCR): Transforming Cancer Treatment with Innovative Self-Amplifying RNA Immunotherapies http://beyondspx.com/2024/08/05/oncorus-inc-nasdaqoncr-transforming-cancer-treatment-with-innovative-self-amplifying-rna-immunotherapies/
View on StockTwits ↗$FNCH like $ONCR on last nasdaq trading Day? Went from 0.08 to 0.33 on last day
View on StockTwits ↗$ONCR I use fidelity.. and do not see dividends yet. Anyone else? With any broker?? You received dividends?
View on StockTwits ↗@Gar_una I don't think it is corrupt at all. Most biotech companies spend everything and go negative before calling it quits. $ONCR executives and board had the guts to call it quits while there was still something left. I give them kudos for that. Biotech research companies are a gamble. Some hit it big. Most fail. Running a research company that doesn't work out doesn't make someone corrupt.
View on StockTwits ↗$ONCR I own 18000 shares on my swedish bank Avanza, and have'nt received any dividend. Anyone else in similar situation?
View on StockTwits ↗$ONCR Congrats to folks who bought for less than 10 cents. You guys made good trade and profit. I sold 500k shares at 0.01 a couple of days back. Feeling very sad that I couldn’t hold till end of December. Anyway god should have other plans for me or that’s what my luck is
View on StockTwits ↗$ONCR payout is $0.1393/sh. •Payment date December 29, 2023 •Record date December 27, 2023 •Ex-dividend date January 2, 2024
View on StockTwits ↗$ONCR big whales covering ehile trading in retail cannot buy nor sell, its gamestock all over
View on StockTwits ↗$ONCR Too bad my swedish broker wont let me sell this, almost at break even...
View on StockTwits ↗@Miok Huh? Totally false. $ONCR has no employees, no products, no CEO, and no board. It's just an accounting firm overseeing the liquidation. $CCCC isn't the same at all.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.